Recordati reported EUR186.98M in Selling and Administration Expenses for its fiscal quarter ending in June of 2025.


Selling And Administration Expenses Change Date
Almirall EUR 91.3M 55.52M Mar/2025
GlaxoSmithKline GBP 2.14B 80M Jun/2025
Hikma Pharmaceutical USD 288M 8M Dec/2024
Orion EUR 96.7M 12.4M Jun/2025
Sanofi EUR 2.63B 408M Jun/2025